Literature DB >> 18467351

Potential misinterpretation of data on differential gene expression in normal and malignant cells in vitro.

Xiaofeng Ye1, Reuben Lotan.   

Abstract

High throughput genomic and proteomic methods are often used for comparisons between expression of genes and proteins, respectively in normal cells and malignant counterparts for the identification of potential tumor markers for diagnosis and prognosis. Some experiments use normal and malignant cells cultured in vitro as a source of the mRNA or proteins for analysis. The conditions used for cell culture can exert major effects on the expression of genes and proteins. The interpretation of results of some such studies can be erroneous if normal cells and cancer cells are cultured in serum-free medium (SFM) and serum-supplemented media, respectively as recommended for their optimal growth. The reason for potential complications in the data interpretation is that serum contains different factors that affect gene expression. Likewise, SFM is usually supplemented with specific growth factors as well as bovine pituitary extract. Experimental examples demonstrating the issue include the stimulatory effects of serum on the expression of retinoic acid-inducible genes (e.g. GPRC5A) leading to the potentially erroneous conclusion that such genes are overexpressed in cancer cells. Potential remedy for this problem is to grow the normal and malignant cells in the same medium (serum-free or serum-containing) before analysis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18467351     DOI: 10.1093/bfgp/eln021

Source DB:  PubMed          Journal:  Brief Funct Genomic Proteomic        ISSN: 1473-9550


  3 in total

Review 1.  The emerging roles of GPRC5A in diseases.

Authors:  Honglei Zhou; Isidore Rigoutsos
Journal:  Oncoscience       Date:  2014-11-25

2.  GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help from HuR.

Authors:  H Zhou; A G Telonis; Y Jing; N L Xia; L Biederman; M Jimbo; F Blanco; E Londin; J R Brody; I Rigoutsos
Journal:  Cell Death Dis       Date:  2016-07-14       Impact factor: 8.469

3.  Production and characterisation of monoclonal antibodies against RAI3 and its expression in human breast cancer.

Authors:  Hannah Jörissen; Nuran Bektas; Edgar Dahl; Arndt Hartmann; Anette ten Haaf; Stefano Di Fiore; Hans Kiefer; Andreas Thess; Stefan Barth; Torsten Klockenbring
Journal:  BMC Cancer       Date:  2009-06-24       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.